NR1H4 and atherosclerosis: Its regulation of lipid metabolism-through modulation of hepatic farnesoid X receptor (FXR) and adipose takeda G protein-coupled receptor 5 (TGR5) signaling-confers protective effects against atherosclerosis and cerebrovascular dysfunction (Wu et al., 2022).